ENLV icon

Enlivex Therapeutics

19 hedge funds and large institutions have $1.24M invested in Enlivex Therapeutics in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
4
Reduced
7
Closed
1
Calls
$449K
Puts
$24K
Net Calls
+$425K
Net Calls Change
-$580K
Name Market Value Shares Shares
Change
Shares
Change %
CLOS
1
Compagnie Lombard Odier SCmA
Switzerland
$225K 65,000 +15,000 +30%
Renaissance Technologies
2
Renaissance Technologies
New York
$199K 54,689 +500 +0.9%
Citadel Advisors
3
Citadel Advisors
Florida
$180K 49,464 -10,068 -17%
Morgan Stanley
4
Morgan Stanley
New York
$146K 40,159 -567 -1%
UBS Group
5
UBS Group
Switzerland
$114K 31,453 -1,992 -6%
Goldman Sachs
6
Goldman Sachs
New York
$68.7K 18,870 -38 -0.2%
SIGI
7
Susquehanna International Group (Ireland)
Ireland
$65K 17,866 -1,021 -5%
Group One Trading
8
Group One Trading
Illinois
$49.1K 13,499
EDRH
9
Edmond de Rothschild Holding
Switzerland
$47.3K 13,000
Simplex Trading
10
Simplex Trading
Illinois
$46K 12,713 +4,560 +56%
Wells Fargo
11
Wells Fargo
California
$38.9K 10,696 -1,050 -9%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$37.9K 10,420
SPIA
13
Steward Partners Investment Advisory
New York
$10.9K 3,000
Barclays
14
Barclays
United Kingdom
$4K 1,000
Bank of America
15
Bank of America
North Carolina
$3.05K 838 +191 +30%
Osaic Holdings
16
Osaic Holdings
Arizona
$1.46K 400
RTL
17
Red Tortoise LLC
Georgia
$546 150
ASN
18
Advisory Services Network
Georgia
$157 43
EE
19
EWG Elevate
California
-100 Closed
JPMorgan Chase & Co
20
JPMorgan Chase & Co
New York
$0 72 -26 -27%
LCH
21
Lee Capital Holdings
New York
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
CFGS
23
Concourse Financial Group Securities
Alabama